Company intelligence / Profile preview

AnteAGE

Irvine, California, United Statesanteage.com ↗

Ownership: Private
Development stage: Other

Overview

AnteAGE’s products are based on decades of clinical research into bone marrow-derived mesenchymal stem cells. Their cornerstone technology was originally developed for diabetic wound healing and has been adapted for anti-aging skincare. Clinical studies have shown improvements in multiple skin parameters including tone, dryness, brightness, pore size, fine lines, and deep lines after five weeks of use. The company also offers solutions for hair regrowth and vaginal rejuvenation with demonstrated efficacy in small clinical studies.

Therapeutic areas: DermatologyWomen's Health
Modalities: Exosome-based therapyGrowth factor therapyCytokine therapy
Industry: Non-Drug Biotech

Partnerships

No major pharma/biotech partnerships publicly disclosed; distributed through med spas/aesthetic clinics globally

Beyond the preview

Go deeper on AnteAGE.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AnteAGE.

Explore the full profile